Related Experiment Video
Updated: Apr 15, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral
Felix P Kuhn1, Geoff Warnock1, Thomas Schweingruber2
1Department of Nuclear Medicine, University Hospital Zurich, Switzerland.
Background:
Moyamoya disease (MMD) is an idiopathic intracranial angiopathy with a progressive spontaneous occlusion of the circle of Willis resulting in repeated ischemia if not diagnosed and treated early, especially in children. Prevention of stroke is achieved by revascularization of the affected cerebral regions. Functional imaging techniques such as H2[(15)O]-Positron emission tomography (PET) allow quantification of cerebral perfusion/blood flow (CBF) and in particular cerebrovascular response after acetazolamide (AZA) challenge. The cerebrovascular reserve (CVR) can then be calculated and used to identify regions at risk of infarct, hence allowing surgery to be specifically targeted and personalized.
Methods:
Pediatric patients with diagnosed MMD underwent initial H2[(15)O]-PET scans at baseline and after stimulation with AZA. Indication for surgery was then based collectively on the extent of disease observed clinically and on magnetic resonance imaging, on the arterial territories involved, as seen in angiography and the respective regional CVR observed in PET. Cerebral revascularization surgeries were subsequently performed, tailored to the individual patient. Postoperative assessment of clinical outcome was augmented with follow-up PET (median duration after surgery, 10.4 months). CBF at baseline, after AZA and CVR were compared between presurgery and postsurgery scans in the areas supplied by the major cerebral arteries.
Results:
Parametric images reflecting CBF, response to AZA and CVR clearly showed deficits in cortical but not subcortical regions or cerebellum. AZA-CBF and CVR deficits were most clear in middle cerebral artery and anterior cerebral artery (ACA) regions. In addition to the clinical symptomatology, angiography, AZA-CBF, and CVR images allowed the laterality of deficits to be clearly visualized for tailored surgery and the indication for targeted ACA or posterior cerebral artery revascularization to be assessed. Comparison of baseline CBF, AZA-CBF, and CVR between presurgery and postsurgery scans in revascularized areas revealed a significant improvement in baseline and AZA-CBF after surgery. Although no significant differences in CVR after revascularization surgery were found, a clear improvement of the deficits apparent in AZA-CBF in revascularized regions was found.
Conclusions:
We demonstrate that quantitative H2[(15)O]-PET is a highly useful tool to direct surgical intervention in MMD. Detailed quantitative analysis of CBF changes and CVR after surgery supports a targeted surgical approach.
Insights
Quantitative H2[(15)O]-PET imaging effectively guides surgical interventions for Moyamoya disease (MMD) in children. Post-surgery scans show improved cerebral blood flow (CBF) and response to acetazolamide (AZA) challenge, confirming the benefits of targeted revascularization.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Moyamoya disease (MMD) is a progressive intracranial angiopathy causing progressive occlusion of the circle of Willis.
- Early diagnosis and treatment, including revascularization surgery, are crucial to prevent stroke, especially in pediatric patients.
- Functional imaging like H2[(15)O]-PET quantifies cerebral blood flow (CBF) and cerebrovascular reserve (CVR) after acetazolamide (AZA) challenge to identify at-risk regions.
Purpose of the Study:
- To evaluate the utility of quantitative H2[(15)O]-PET in guiding personalized surgical revascularization for pediatric Moyamoya disease.
- To assess the impact of revascularization surgery on CBF and CVR in MMD patients.
Main Methods:
- Pediatric MMD patients underwent baseline and post-acetazolamide (AZA) H2[(15)O]-PET scans.
- Surgical indications were determined by clinical presentation, imaging, and PET-derived CVR.
- Cerebral revascularization surgeries were performed, followed by postoperative PET assessment (median 10.4 months).
- Presurgery and postsurgery CBF and CVR were compared in revascularized arterial territories.
Main Results:
- H2[(15)O]-PET revealed significant CBF and CVR deficits primarily in cortical regions supplied by the middle cerebral artery and anterior cerebral artery (ACA).
- PET imaging facilitated visualization of deficit laterality, aiding in tailored surgical planning for ACA or posterior cerebral artery revascularization.
- Post-surgery PET scans demonstrated significant improvements in baseline CBF and AZA-induced CBF in revascularized areas.
- While CVR did not significantly change, improved AZA-CBF response indicated enhanced cerebrovascular function after surgery.
Conclusions:
- Quantitative H2[(15)O]-PET is a valuable tool for directing surgical interventions in Moyamoya disease.
- Detailed quantitative analysis of CBF and CVR post-surgery supports the efficacy of a targeted surgical approach in MMD.

